These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2520504)

  • 21. When scientists become policy makers.
    Pease WS
    Reprod Toxicol; 1991; 5(6):525-6. PubMed ID: 1810579
    [No Abstract]   [Full Text] [Related]  

  • 22. Reproductive toxicity testing of vaccines.
    Verdier F; Barrow PC; Burge J
    Toxicology; 2003 Apr; 185(3):213-9. PubMed ID: 12581696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. California Stem Cell Research and Cures Act: what to expect from stem cell research?
    Panetta J; Wetherell J; Mehok M
    J Biolaw Bus; 2005; 8(4):3-12. PubMed ID: 16619447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of exposure margins in developmental toxicity studies for detection of human teratogens.
    Andrews PA; Blanset D; Costa PL; Green M; Green ML; Jacobs A; Kadaba R; Lebron JA; Mattson B; McNerney ME; Minck D; Oliveira LC; Theunissen PT; DeGeorge JJ
    Regul Toxicol Pharmacol; 2019 Jul; 105():62-68. PubMed ID: 30981719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicological assessment of epinephrine and norepinephrine by analog approach.
    Aydın A; Tugcu G
    Food Chem Toxicol; 2018 Aug; 118():726-732. PubMed ID: 29913233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS; Brent RL
    Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A strategy for safety assessment of chemicals with data gaps for developmental and/or reproductive toxicity.
    Blackburn K; Daston G; Fisher J; Lester C; Naciff JM; Rufer ES; Stuard SB; Woeller K
    Regul Toxicol Pharmacol; 2015 Jul; 72(2):202-15. PubMed ID: 25910676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. California's cancer warning.
    Consum Rep; 2013 Mar; 78(3):10. PubMed ID: 23556194
    [No Abstract]   [Full Text] [Related]  

  • 29. The environmental injustice of beauty: framing chemical exposures from beauty products as a health disparities concern.
    Zota AR; Shamasunder B
    Am J Obstet Gynecol; 2017 Oct; 217(4):418.e1-418.e6. PubMed ID: 28822238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atenolol developmental toxicity: animal-to-human comparisons.
    Tabacova S; Kimmel CA; Wall K; Hansen D
    Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):181-92. PubMed ID: 12797460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP 12th Report on Carcinogens.
    National Toxicology Program
    Rep Carcinog; 2011; 12():iii-499. PubMed ID: 21822324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental and reproductive toxicity testing of vaccines.
    Barrow P
    J Pharmacol Toxicol Methods; 2012 Mar; 65(2):58-63. PubMed ID: 22233769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A regulatory approach to assess the potency of substances toxic to the reproduction.
    Muller A; Blaude MN; Ihlemann C; Bjorge C; Ohlsson A; Gebel T
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):97-105. PubMed ID: 22410176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the toxicology of acrylamide.
    Exon JH
    J Toxicol Environ Health B Crit Rev; 2006; 9(5):397-412. PubMed ID: 17492525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods.
    Brown NA
    Altern Lab Anim; 2002; 30(2):177-98. PubMed ID: 11971754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multigenerational reproductive study of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Mar; (539):1-266. PubMed ID: 18685713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of reproductive toxicity and classification of glufosinate-ammonium.
    Schulte-Hermann R; Wogan GN; Berry C; Brown NA; Czeizel A; Giavini E; Holmes LB; Kroes R; Nau H; Neubert D; Oesch F; Ott T; Pelkonen O; Robert-Gnansia E; Sullivan FM
    Regul Toxicol Pharmacol; 2006 Apr; 44(3 Suppl 1):S1-76. PubMed ID: 16510221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Great lakes research--important human health findings and their impact on ATSDR's Superfund research program.
    Hicks HE; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):49-61. PubMed ID: 12018016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weight-of-the-evidence review of acrylonitrile reproductive and developmental toxicity studies.
    Neal BH; Collins JJ; Strother DE; Lamb JC
    Crit Rev Toxicol; 2009; 39(7):589-612. PubMed ID: 19650719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative Models of Developmental and Reproductive Toxicity in Pharmaceutical Risk Assessment and the 3Rs.
    Brannen KC; Chapin RE; Jacobs AC; Green ML
    ILAR J; 2016 Dec; 57(2):144-156. PubMed ID: 28053068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.